WINSTON-SALEM — A Winston-Salem-based startup has raised $300,000 in a private stock offering, according to a filing with the Securities and Exchange Commission.

Nvolve Inc., a medical management company, filed the Form D Wednesday. The company plans on selling another $1.2 million worth of stock, for a total private equity raise of $1.5 million. It first started selling stock Jan. 16.

The company, founded in 2013, did not disclose what it intends to do with the proceeds.

Nvolve produces a system that enables patients to know when and how much medication they are taking. The company’s CEO is Andrew Bowline, and its CIO is Adam Oakman. The company provides systems for individuals and hospitals.

According to its website:

  • The NVOLVE medication adherence system is simpler and more advanced than any system on the market today
  • The NVOLVE medication box was designed from the ground up, with significant improvements for aging patients and medication management services
  • Your patients simply store the medication box in the NVOLVE base station, where we monitor when and how much medication is being taken and intervene when necessary
  • Most importantly, your patients do not have to change their behaviors or learn any new technology to use NVOLVE

The company was called N2 Medical Solutions and now goes by Nvolve Inc.

This story is from the North Carolina Business News Wire, a service of UNC-Chapel Hill’s School of Media and Journalism